Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Cigna GroupWBO:CIGN -1.24%67 Days Sales Outstanding is 36.63 as of Jun. 2026, which is 17% below its 10-year median of 44.22. GuruFocus rates WBO:CIGN with a GF Score™ of 67/100 and a GF Value™ of €343.00 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 14 Healthcare Plans companies, The Cigna Group ranks better than 50% on this metric.
The Cigna Group's average Accounts Receivable for the
three
months ended in Jun. 2026 was €24,875 Mil. The Cigna Group's Revenue for the
three
months ended in Jun. 2026 was €61,972 Mil.
Hence, The Cigna Group's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 36.63.
The historical rank and industry rank for The Cigna Group's Days Sales Outstanding or its related term are showing as below:
WBO:CIGN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.41 Med: 44.22 Max: 91.52
Current: 38.67
During the past 13 years, The Cigna Group's highest Days Sales Outstanding was 91.52. The lowest was 25.41. And the median was 44.22.
WBO:CIGN's Days Sales Outstanding is ranked better than 50% of 14
companies
in the Healthcare Plans industry
Industry Median: 41.405
vs WBO:CIGN: 38.67
The Cigna Group's Days Sales Outstanding
declined
from Jun. 2025 (40.81) to Jun. 2026 (36.63).
The Cigna Group (WBO:CIGN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
The Cigna Group Days Sales Outstanding Related Terms
The Cigna Group Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for The Cigna Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:CIGN vs ELV, HUM, CNC: Days Sales Outstanding Comparison
For the Healthcare Plans subindustry, The Cigna Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cigna Group Days Sales Outstanding vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, The Cigna Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where The Cigna Group's Days Sales Outstanding falls into.
The Cigna Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Cigna Group (WBO:CIGN) has a Days Sales Outstanding of 36.63 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on The Cigna Group and its competitors. This is 17% below median its historical median of 44.22. Over the past decade, The Cigna Group's Days Sales Outstanding has ranged from 25.41 to 91.52. According to the industry distribution chart, The Cigna Group ranks #7 out of 14 companies in the Healthcare Plans industry, placing it in the top 50%.
Is The Cigna Group's Days Sales Outstanding too high?
The Cigna Group's current Days Sales Outstanding of 36.63 is 17% below median its 10-year median of 44.22. Over the past 10 years, this metric has ranged from a low of 25.41 to a high of 91.52. The Healthcare Plans industry median Days Sales Outstanding is 41.41. The Cigna Group's value of 36.63 is 11.5% below this industry median. Based on the distribution chart, The Cigna Group ranks #7 out of 14 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, The Cigna Group has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's Days Sales Outstanding compare to ELV and HUM?
According to the Healthcare Plans industry distribution chart, The Cigna Group ranks #7 out of 14 companies for Days Sales Outstanding. This puts The Cigna Group in the upper half of its industry. The industry median Days Sales Outstanding is 41.41. The Cigna Group's value of 36.63 is 11.5% below this benchmark. Historically, The Cigna Group's own Days Sales Outstanding has ranged from 25.41 to 91.52 over the past decade. While the company's 10-year median is 44.22 vs. the industry median of 41.41, The Cigna Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Plans company?
The median Days Sales Outstanding among Healthcare Plans companies is 41.41, based on 14 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Cigna Group's current Days Sales Outstanding of 36.63 is 11.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on The Cigna Group and its competitors. For the Healthcare Plans industry, the median Days Sales Outstanding is 41.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Cigna Group's current Days Sales Outstanding is 36.63, which is 17% below median its own 10-year median of 44.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Significantly Undervalued. The stock's GF Value™ is €343.00, compared to a current price of €239.60 — trading 30.1% below its estimated fair value. The current Days Sales Outstanding is 36.63, which is 17% below median its 10-year median of 44.22 and 11.5% below the Healthcare Plans industry median of 41.41. The Cigna Group's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current Days Sales Outstanding is 36.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Cigna Group (WBO:CIGN) Overvalued in 2026?
Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued.
The current stock price of €239.60 is trading 30.1% below its estimated GF Value™ of €343.00.
GuruFocus considers The Cigna Group to be Significantly Undervalued.
Key valuation signals for WBO:CIGN:
Days Sales Outstanding: 36.63 (17% below median its 10-year median of 44.22)
GF Value™: €343.00 vs. price of €239.60 (30.1% below fair value)
Industry Position: 11.5% below the Healthcare Plans median (#7 of 14)
No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
67GF Score
Get the complete analysis for WBO:CIGN
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:CIGN has been successfully added to your 
